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scores representing better outcomes), then regressed
against selected independent variables.
RESULTS: Multivariable regression analyses showed that
sexual function scores were significantly lower in the RP
groups than in the XRT group (p < 0.001) three months
after treatment. Improvement in sexual function over
time was better in those undergoing RP with nerve spar-
ing, compared to non-nerve sparing (p = 0.08) or XRT
(p = 0.006). The non-nerve sparing group showed a
trend toward greater improvement in sexual function
compared to XRT (p = 0.12). Younger age was a signifi-
cant predictor of sexual function and post-treatment im-
provement, but disease stage was not. No significant dif-
ferences were found in sexual bother scores among the
three treatments.
CONCLUSIONS: Significant differences in sexual func-
tion are found between patients undergoing RP versus
XRT for prostate cancer. Men undergoing nerve sparing
RP showed greater improvements in sexual function than
either XRT or non-nerve sparing RP patients. Sexual
bother from dysfunction may be explained by non-
treatment-related variables.
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Stroke is the third leading cause of death in Germany and
the major source of disability in persons older than 60
years of age.
OBJECTIVE: In a retrospective analysis, the cost structure
of the screening of risk factors for stroke was inquired.
This analysis is a cost-effectiveness analysis and centred
around the question how many strokes are avoided as a re-
sult of the screening, expressed in a cost-effective ratio.
METHODS: Five risks factors for stroke are distin-
guished. These risk factors can occur on their own or to-
gether and were (a) controlled, (b) not controlled, or (c)
not obvious. A decision tree with 90 endpoints was con-
structed. The probability of stroke for the five risk factors
was taken from a study describing a risk profile from the
Framingham population. The period of the model was 10
years. Health care costs included in the model were all
medical costs (hospitalization, drug costs, etc.) and indi-
rect costs (absence from workplace, burial allowance).
RESULTS: Per patient the screening caused direct costs
of 1,272.93 DM and indirect costs of 1,034.71 DM.
Without a screening there are direct costs of 1,173.65
DM and indirect costs of 948.52 DM. Screening is hence
the cost-intensive alternative. The cost-effective ratio is
the difference of direct costs divided by avoided strokes.
To avoid one stroke, 150,000.00 DM must be invested.
For a better comprehension of the results, sensitivity
analyses were conducted to determine the influence of the
efficacy on the effectiveness adjusted costs of stroke and
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the effects of the frequency of modified assumptions of
the model.
CONCLUSION: This decision tree analysis reveals that
screening of risk factors for stroke is not the. If the costs
of stroke were 182,000.00 DM, then screening would be
the lowest cost alternative.
